Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …

Introduction Intrahepatic cholangiocarcinoma (ICC) incidence continues to rise worldwide,
and overall survival remains poor. Complete surgical resection remains the only opportunity …

Background and aims Currently, there are still no definitive consensus in the treatment of
intrahepatic cholangiocarcinoma (iCCA). This study aimed to build a clinical decision …

Abstract Background Hepatitis B virus (HBV) infection is one of the most common risk factors
for intrahepatic cholangiocarcinoma (ICC). However, there is no direct evidence of a causal …

Background The prognostic significance of tumor burden score (TBS) on patients who
underwent curative-intent resection of intrahepatic cholangiocarcinoma (ICC) has not been …

Background The optimal time interval to define early recurrence (ER) among patients who
underwent resection of gallbladder cancer (GBC) is not well defined. We sought to develop …

Background Although multidisciplinary treatments including the use of adjuvant therapy (AT)
have been adopted for biliary tract cancers, patients with distal cholangiocarcinoma (DCC) …

Primary cancers of the liver and biliary tract are rare and aggressive tumors that often
present with locally advanced or metastatic disease. For patients with localized disease …

As a consequence of breakthroughs in the area of guidelines research, the therapy for
cholangiocarcinoma has significantly improved the efficacy rate of diagnosis and survival …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer
behind hepatocellular carcinoma (HCC) and carries a dismal prognosis. Improved genetic …